Skip to content
Clinical ResearchResearch compoundStrong evidence

Huperzine‑A

Reversible AChE inhibitor, isolated from the Chinese moss Huperzia serrata.

NootropicCholinergicAlkaloidCholinergicAChE InhibitorAcetylcholineNMDA

Pharmacology

ClassAlkaloid · Cholinergic · AChE Inhibitor
Primary targetAcetylcholinesterase (AChE)
Targets3 receptor targets
EvidenceStrong evidence
Affected systemsAcetylcholineNMDA

Contents

WHAT IS HUPERZINE-A?

Detailed overview

Huperzine-A is an alkaloid isolated from the moss Huperzia serrata. It is a potent, reversible and selective acetylcholinesterase (AChE) inhibitor – more selective than Donepezil – gating prolongs acetylcholine signaling in the synaptic cleft. Clinically improves cognitive function in Alzheimer`s disease (meta-analysis PMID 33851462; rodent meta PMID 36499562). Provides neuroprotection via Wnt signaling, amyloid-β accumulation, and synaptic pathway modulation (PMID 34770940). Anecdotally induces vivid / lucid dreaming (the most common community-reported side effect). Long half-life (~10-14h) makes cycling mandatory – 2-4 weeks on / 2-4 weeks off, otherwise sustained AChE suppression causes cholinergic overload. Used as a drug in China for Alzheimer`s disease; sold as a dietary supplement in the West.

Mechanism

Reversible AChE inhibitor

Half-life

~10-14 h

Legal status

China Rx / Western OTC supplement

Receptor profile

  • Acetylcholinesterase (AChE)Strong
  • NMDA receptorsModerate
  • Mitochondria / beta-amyloid stressModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Vivid, often lucid dreams and disturbed sleep (the most commonly reported effect)
  • Nausea, stomach upset, diarrhea (cholinergic excess)
  • Increased salivation and sweating
  • Muscle twitching, cramps, fasciculation
  • Dizziness, slow heart rate (bradycardia)
  • Headache, fatigue, irritability with prolonged use

Contraindications · 6

  • Do not combine with other AChE inhibitors (donepezil, rivastigmine, galantamine): additive cholinergic toxicity
  • Caution with bradycardia or cardiac conduction disorders (vagotonic effect)
  • Asthma, COPD: cholinergic tone can trigger bronchospasm
  • Epilepsy / seizure susceptibility: may lower seizure threshold
  • Avoid with peptic ulcer or gastrointestinal obstruction
  • Not advised in pregnancy or breastfeeding; cycling required due to long half-life (2-4 weeks on / off)

Related Nootropics

Same therapeutic category

FAQ

FAQ

Huperzine-A is mainly used to support memory and cognitive function: derived from a Chinese moss, it slows the breakdown of acetylcholine, a brain messenger chemical important for learning and memory, so more of it stays active in the brain. It's a potent, selective compound, but the source material doesn't cite a specific human trial result here, so its memory benefit is more of a mechanism-based inference than a proven clinical outcome.

Telegram

Have a question about Huperzine‑A?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC15H18N2O
UpdatedJune 19, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.